| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MIRVALA 21 | 0.1500MG 0.0300MG | TABLET | Resolved | 2025-08-07 | 2025-08-15 | 264558 |
| MIRVALA 21 | 0.0300MG 0.1500MG | TABLET | Resolved | 2022-10-21 | 2022-11-07 | 172355 |
| MIRVALA 21 | 0.1500MG 0.0300MG | TABLET | Resolved | 2018-07-04 | 2018-07-12 | 54312 |
| MIRVALA 28 | 0.0300MG 0.1500MG | TABLET | Resolved | 2022-01-14 | 2022-01-18 | 152779 |
| MIRVALA 28 | 0.1500MG 0.0300MG | TABLET | Resolved | 2019-01-30 | 2019-04-26 | 74028 |
| MIRVALA 28 | 0.1500MG 0.0300MG | TABLET | Resolved | 2018-07-04 | 2018-07-12 | 54315 |
| MIRVALA 28 | 0.0300MG 0.1500MG | TABLET | Resolved | 2024-08-22 | 2024-10-18 | 235701 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2025-10-30 | 2025-11-07 | 270735 |
| MYA | 0.02MG 3.00MG | TABLET | Actual shortage | 2026-01-15 | 2026-01-15 | 276172 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2025-05-08 | 2025-05-16 | 256899 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRI-CYCLEN LO (21 DAY) | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | To be discontinued | 2019-08-22 | 2020-05-08 | 92260 |
| TRI-CYCLEN LO (21 DAY) | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | To be discontinued | 2019-12-20 | 2019-12-20 | 101820 |
| TRI-CYCLEN LO (28 DAY) | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | To be discontinued | 2019-08-22 | 2020-05-08 | 92263 |
| TRI-CYCLEN TABLETS - 21-DAY | 0.035MG 0.035MG 0.035MG 0.18MG 0.215MG 0.25MG | TABLET | Discontinued | 2019-08-22 | 2020-06-03 | 92254 |
| TRI-CYCLEN TABLETS - 28-DAY | 0.035MG 0.035MG 0.035MG 0.18MG 0.215MG 0.25MG | TABLET | Discontinued | 2019-08-22 | 2020-03-05 | 92257 |